0001144204-19-035107.txt : 20190719 0001144204-19-035107.hdr.sgml : 20190719 20190719070036 ACCESSION NUMBER: 0001144204-19-035107 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190718 FILED AS OF DATE: 20190719 DATE AS OF CHANGE: 20190719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSENWALD LINDSAY A MD CENTRAL INDEX KEY: 0000941841 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35366 FILM NUMBER: 19962302 MAIL ADDRESS: STREET 1: 375 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10152 FORMER NAME: FORMER CONFORMED NAME: ROSENWALD LINDSAY MD DATE OF NAME CHANGE: 19950316 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fortress Biotech, Inc. CENTRAL INDEX KEY: 0001429260 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205157386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC DATE OF NAME CHANGE: 20080310 4 1 tv525484_4.xml OWNERSHIP DOCUMENT X0306 4 2019-07-18 0 0001429260 Fortress Biotech, Inc. FBIO 0000941841 ROSENWALD LINDSAY A MD C/O FORTRESS BIOTECH, INC. 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 1 1 1 0 PRESIDENT, CEO & CHAIRMAN COMMON STOCK, PAR VALUE $0.001 2019-07-18 4 A 0 396825 1.26 A 8569722 D Shares acquired as a result of prepayment of debt owed to Dr. Rosenwald that was held in the name of Opus Point Healthcare Innovations Fund, LP ("Opus"), an investment fund co-owned by Dr. Rosenwald, in the form of the Company's common stock (measured at the closing price on July 18, 2019), under that certain Amended & Restated Credit Facility Agreement, dated as of March 12, 2018, by and between the Company and Opus. /s/ Samuel W. Berry / Attorney in Fact 2019-07-19